"10.1371_journal.pone.0046509","plos one","2012-10-17T00:00:00Z","Robert Booy; Richard I Lindley; Dominic E Dwyer; Jiehui K Yin; Leon G Heron; Cameron R M Moffatt; Clayton K Chiu; Alexander E Rosewell; Anna S Dean; Timothy Dobbins; David J Philp; Zhanhai Gao; C Raina MacIntyre","National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The University of Sydney, Sydney, New South Wales, Australia; Discipline of Medicine, The University of Sydney and The George Institute for Global Health, Sydney, New South Wales, Australia; Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital and Sydney Institute for Emerging Infections and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia; Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia; School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia; Faculty of Medicine, School of Public Health and Community Medicine, The University of New South Wales, Sydney, New South Wales, Australia","Conceived and designed the experiments: RB RIL DED CRM. Performed the experiments: RB RIL DED JKY LGH CRMM CKC AER ASD CRM. Analyzed the data: RB RIL DED JKY TD DJP ZG CRM. Contributed reagents/materials/analysis tools: DED. Wrote the paper: RB RIL DED JKY LGH CRMM CKC AER ASD TD DJP ZG CRM.","Richard Lindley has been a paid consultant for CSL in his role of Chairman of Data Monitoring Committees for influenza vaccines. He currently holds the position of Moran Foundation for Older Australians Professor of Geriatric Medicine. The Moran Health Care group were the industrial partners for this study. Robert Booy has received funding from CSL, Roche, Sanofi, GlaxoSmithKline (GSK) and Wyeth to attend and present at scientific meetings; any funding received is directed to a research account at the Childrens Hospital at Westmead. Leon Heron has performed consultancy work for Novartis for which payment was made to the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. He has had travel expenses covered by GSK and Sanofi Pasteur and has conducted sponsored research and investigator-driven research with funding from GSK, Wyeth, Merck, CSL, Roche, and Sanofi Pasteur. David J. Philps university has received support from GSK and CSL to perform work on pneumococcal transmission and HPV transmission and vaccination and has received payment from CSL for consultancy. The trial was also supported by Roche, but this support does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Robert Booy","RB",13,TRUE,4,10,8,13,TRUE,TRUE,FALSE,0,NA,FALSE
